CRMD - CorMedix Inc
(NaN%)
Sell
Weak Growth●Stock Price Very High
31%
based on last 5 year data.
Income Statement is WEAK
Revenue Growth is 1299.72%
Operating Income turning Positive
Net Income turning Positive
Earnings Per Share (EPS) turning Positive
Net Margin is 81.4%
Balance Sheet is STRONG
Current Asset to Current Liability Ratio is 1.94
Debt Ratio is 0.5
Current Debt to Net Income Ratio is 0.0
Total Debt to Total Assets Ratio is 0.0
Cash Flow is WEAK
Cash from Operations turning Positive
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is NEUTRAL
Investment Risk is High
based on last 4 quarter data.
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
CorMedix Inc (CRMD) - http://www.cormedix.com/
cormedix inc. is a company based out of 745 route 202-206, suite 303, bridgewater, nj, united states.Exchange - NASDAQ
Industry - Pharmaceutical Preparation Manufacturing
Sector - Manufacturing
CEO - Khoso Baluch
Employees - 54
Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2025 and future.
Know the Stock © 2025 and future.